Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments.
Ten physicochemical variables have been calculated for each of 100 different aromatic rings. These variables were selected because of their potential involvement in the molecular recognition of drug-receptor binding interactions, and they include size, lipophilicity, dipole magnitude and orientation, HOMO and LUMO energies, and electronic point charges. A total of 59 different aromatic ring systems were studied including monocyclics and [5.5]-, [6.5]- and [6.6]-fused bicyclics. A principal components analysis of b1ese results generated four principal components which account for 84% of the total variance in the data. These principal components provide a quantitative measure of molecular diversity, and their relevance for structure-activity relationships is discussed. The principal components correlate with the in vitro biological activity of heterocyclic aromatic fragments within a series of previously reported HIV-1 reverse transcriptase inhibitors.
Gibson
S
S
Department of Medicinal Chemistry, Organon Research Laboratories, Scotland, U.K.
McGuire
R
R
Rees
D C
DC
D055598:Chemical Phenomena; D002627:Chemistry, Physical; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006571:Heterocyclic Compounds / Q000737:chemistry*; D015394:Molecular Structure; D011084:Polycyclic Aromatic Hydrocarbons / Q000737:chemistry*; D018894:Reverse Transcriptase Inhibitors / Q000737:chemistry; D012984:Software; D013223:Statistics as Topic; D013329:Structure-Activity Relationship
D006571:Heterocyclic Compounds; D011084:Polycyclic Aromatic Hydrocarbons; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase